CYTOSOMATIC LABSCanadian / PRECLINICAL NEUROSCIENCE

PRECLINICAL NEUROSCIENCE

AdvancingNeuroscience.

Building the Framework
for Neural Restoration.

Preclinical neuroscience built around one principle: understand the mechanism before attempting to change the outcome.

SCROLLMECHANISM → EVIDENCE → RESTORATION
01

CELLULAR MECHANISMS

Disease changes biology before it changes possibility.

WE STUDY THE FAILURE OF THE NERVOUS SYSTEM AT ITS ORIGIN.

Interrogate neurological dysfunction at the level of cells, signalling and neural architecture.

02

NEURAL RENEWAL

FROM REACTIVE CARE TO NEURAL RENEWAL

Ask what function can return, and test recovery through biological and functional readouts.

03

RESEARCH DIRECTION

INTERCEPT. REPAIR. RESTORE.

Distinguish biological signal from noise, and measure the neural and immune state behind the diagnosis.

Investigate cellular vulnerability alongside the pathways and functions that remain.

THE RESEARCH, TODAY

RESEARCH PROGRAMMES
03
PIPELINE RANGE
P0–P2
RAW DATA SHARED
BY AGREEMENT

Discovery through construct validation defines the framework, not completed stages. Underlying data are made available to collaborators within consent, privacy and agreed sharing constraints.

RESEARCH STAGE
DISCOVERY / PRECLINICAL
CLINICAL TRIALS
NOT CURRENTLY CONDUCTED
RESEARCH PROGRAMMES
03

05 / RESEARCH PROGRAMMES

Three programmes.
One nervous system.

CSL-R-02Active — discovery / preclinical

NEURAL
CELL THERAPY

Neural × Immune

Our most active line of work, though not the whole of our research. We investigate engineered cell-therapy architectures adapted for neuroinflammatory and neurodegenerative disease, where the target is a pathogenic glial or immune cell population within the nervous system rather than a tumour. The programme is organised around construct design, safety modelling and neural mechanism readouts.

Research focus
  • Cell engineering research

    Construct design, transduction efficiency, and vector-free delivery approaches evaluated across donor-derived neural and immune co-cultures.

  • Safety and tolerability studies

    Cytokine and neuroinflammatory release characterisation, on-target/off-tissue modelling, and engineered safety-switch evaluation in vitro.

  • Mechanism investigation

    Single-cell readouts of neural-immune interaction, expansion, exhaustion and memory phenotype to explain why a construct behaves as it does.

Explore programme
CSL-R-01Assay development

NEURO-
DIAGNOSTICS

Signal × State

Therapy decisions are only as good as the neural and immune picture behind them. We build high-dimensional profiling assays that describe a patient’s neurological and neuroimmune state with enough resolution to stratify who might respond to a given intervention.

Research focus
  • Neural profiling

    Multi-parameter cytometry and transcriptional panels covering neuronal, glial and neuroimmune compartments.

  • Biomarker discovery

    Candidate markers of neural dysfunction validated across independent sample cohorts.

  • Patient stratification

    Statistical models that group patients by mechanism rather than by symptom label alone.

Explore programme
CSL-R-03Exploratory

NEURO-
RESTORATION

Damage × Recovery

For patients whose nervous systems are depleted by disease or treatment, restoration is the goal rather than suppression. This programme studies how compromised neural compartments recover, and what can be done to accelerate that recovery safely.

Research focus
  • Cell regeneration

    Ex vivo expansion and differentiation protocols for depleted neural and supporting cell populations.

  • Function recovery

    Functional assays that measure restored neural response, not just restored cell counts.

  • Neural enhancement

    Adjunct strategies evaluated for durability and neuroinflammatory risk.

Explore programme

06 / METHODS + REPRODUCIBILITY

Scientific
operating system.

  1. 01

    DEFINE

    Define the scientific question and study architecture before collection.

  2. 02

    MEASURE

    Capture the underlying biological signal.

  3. 03

    REPRODUCE

    Reproduce key findings with independent and orthogonal methods.

  4. 04

    INTERROGATE

    Challenge the interpretation against the underlying record.

  5. 05

    RETAIN

    Preserve negative and null results.

Study designs, method files and negative or null results belong alongside positive findings. Underlying data are made available to collaborators within consent, privacy and agreed sharing constraints.

Research questions
What does Cytosomatic Labs research?
We are a neuroscience biotechnology lab running preclinical research in three areas — neural cell therapy, neurodiagnostics and neurorestoration — focused on neurodegenerative and autoimmune disease.
What stage is the research at?
Discovery and preclinical. We do not run clinical trials today. Programme stages are labelled on this page so collaborators know exactly what exists.
Who do you collaborate with?
Academic neuroscience groups, clinical investigators, translational funds, and instrument partners. Collaborators receive raw datasets and method files, not only summaries.
Where is Cytosomatic Labs based?
Toronto, Ontario, Canada.

07 / RESEARCH PIPELINE

Evidence before
advancement.

A sequence of scientific questions, not a claim of completed development. Research remains discovery / preclinical; clinical trials are not currently conducted.

  1. P0

    MECHANISM

  2. P1

    TARGET

  3. P2

    ASSAY

  4. P3

    VALIDATION

  5. P4

    FUNCTION

Development pipeline

08 / CYTOSOMATIC LABS

BUILD THE EVIDENCE FIRST.EARN THE THERAPY SECOND.

Canadian / PRECLINICAL NEUROSCIENCE

09 / KNOWLEDGE HUB

Read below
the surface.

01 / Neuroinflammation

Neuroinflammation

Immune signalling in the nervous system can support repair or contribute to injury. Its interpretation depends on cell state, timing and tissue context.

02 / Cellular repair

Neurodegeneration

Neurodegeneration describes progressive loss of neuronal structure or function. Protein handling, energy supply, axonal transport and immune state can interact in that decline.

03 / Cellular repair

Neural repair

Neural repair encompasses axonal responses, remyelination, synaptic adaptation and supporting-cell activity. Structural recovery and functional recovery are related but are not interchangeable.

04 / Neuroinflammation

Neuroimmune interactions

Neurons, glia and immune cells communicate through soluble signals, contact-dependent pathways and barrier interfaces. These interactions shape both tissue maintenance and disease responses.

05 / Neurodiagnostics

Neurodiagnostics

Neurodiagnostics connects biological measurement with questions about nervous-system state. Analytical validity, biological interpretation and clinical utility are separate evidence requirements.

06 / Cellular repair

Neural stem-cell niches

A neural stem-cell niche is the local environment that regulates progenitor maintenance and differentiation. Vascular, glial, extracellular and immune signals influence that environment.

07 / Neuroinflammation

Glial biology

Glial biology connects cell identity, tissue context and neural function. This guide separates astrocyte reactivity, microglial states and oligodendrocyte-lineage repair, then maps the measurements needed to interpret each without overstating preclinical evidence.

08 / Neurodiagnostics

Functional neural assays

Functional neural assays measure activity, connectivity, conduction or responses to controlled stimulation. They complement molecular and cellular descriptions of a model.

All scientific articles Collaborate